Ventriculoperitoneal Shunt Infection and Treatment in Children
Abstract
Purpose: The most important complication of ventriculoperitoneal shunt (VPS) surgery is central nervous system infections developing in the postoperative period. The incidence of VPS infection in cases with VPS inserted is known to be between 6.5-23.5%. The aim of this study is to evaluate the treatment and complications relating to VPS surgery infections in pediatric patients with hydrocephalus. Material and Methods: Patients between January 2011 and January 2013 with VPS inserted for hydrocephalus and complications relating to infections after surgical intervention were included in the study. The patient files were retrospectively investigated and analyzed. Patients were evaluated based on demographic characteristics, etiology of hydrocephalus, date of shunt insertion, operation notes from the VPS insertion operation, microbiological and Araştırma Makalesi / Research Article 72 Cilt/Volume 40 Yıl/Year 2015 Ventriküloperitoneal Şant Enfeksiyonları biochemical test results on CSF samples after diagnosis of VPS infection, surgical intervention for treatment, antibiotics administered and duration of antibiotic use. Results: Thirty-five patients monitored for VPS infection diagnosis between the ages of 3 days and 16 years were evaluated. In the 35 patients monitored for VPS infection diagnosis 19 had growth in cerebrospinal fluid (CSF) while 17 patients had no growth in CSF but inflammatory findings were present. The most frequently isolated effective pathogens were coagulase-negative staphylococci (78%). Other microorganisms isolated in the CSF of patients were Staphylococcus aureus, Enterococcus feacalis, Enterococcus gallinarium, Pseudomonas stutzeri, Candida albicans, Streptococcus mitis and ESBL (-) Klebsiella pneumonia. While one patient died during treatment, 34 patients were successfully discharged. Conclusion: We believe that early administration of antibiotic treatment and removal of the infected shunt are of vital importance.
Keywords
Kaynakça
- Davis SE, Levy ML, McComb JG, Masri-Lavine L. Does age or other factors influence the incidence of ventriculoperitoneal shunt infections? Pediatr Neurosurg. 1999;30:253-7.
- Tuan TJ, Thorell EA, Hamblett NM, Kestle JR, Rosenfeld M, Simon TD. Treatment and microbiology of repeated cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J. 2011;30:731-5.
- and future. Acta Neurochir (Wien). 1992;116:155-60.
- Amacher AL, Wellington J. Infantile hydrocephalus: long-term results of surgical therapy. Childs Brain. 1984;11:217-29.
- Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien ). 1995;136:1-7.
- Cochrane DD, Kestle JR. The influence of surgical operative experience on the duration of first ventriculoperitoneal shunt function and infection. Pediatr Neurosurg. 2003;38:295-301.
- Di RC, Marchese E, Velardi F. A survey of the first complication of newly implanted CSF shunt devices for the treatment of nontumoral hydrocephalus. Cooperative survey of the 1991-1992 Education Committee of the ISPN. Childs Nerv Syst. 1994;10:321-7.
- Frykberg T, Olden L. Infection as a cause of peritoneal catheter dysfunction in ventriculo- peritoneal shunting in children. Z Kinderchir 1983;38:84-6.
- Kestle J, Drake J, Milner R, Sainte-Rose C, Cinalli G, Boop F, et al. Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg. 2000;33:230- 6.
- Vinchon M, Dhellemmes P. Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst. 2006;22:692-7.
